Upgrade to SI Premium - Free Trial

Catalyst Pharmaceuticals (CPRX)

31.49 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26 *Est.)

Latest Headlines

Form 15-12G CATALYST PHARMACEUTICALS July 24, 2026 2:49 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Curran Daniel J. July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Tierney David S July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Elsbernd Brian July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Miller Steve July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Russo Gregg July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Thompson Tamar July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Del Carmen Jeffrey July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: MCENANY PATRICK J July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Sundaram Preethi July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Daly Richard J July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Kalb Michael Wayne July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: DENKHAUS DONALD A July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Andrews William T. July 17, 2026 4:16 PM - SEC Filing Form 4 CATALYST PHARMACEUTICALS For: Jul 15 Filed by: Harper Molly July 17, 2026 4:16 PM - SEC Filing Form EFFECT CATALYST PHARMACEUTICALS July 17, 2026 6:04 AM - SEC Filing Form EFFECT CATALYST PHARMACEUTICALS July 17, 2026 6:04 AM - SEC Filing Form EFFECT CATALYST PHARMACEUTICALS July 17, 2026 6:03 AM - SEC Filing Form EFFECT CATALYST PHARMACEUTICALS July 17, 2026 6:03 AM - SEC Filing Form EFFECT CATALYST PHARMACEUTICALS July 17, 2026 6:03 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:03 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form S-8 POS CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POSASR CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POS AM CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POS AM CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POS AM CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POS AM CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form POS AM CATALYST PHARMACEUTICALS July 16, 2026 6:02 AM - SEC Filing Form 8-K CATALYST PHARMACEUTICALS For: Jul 15 July 16, 2026 6:01 AM - SEC Filing Angelini Pharma acquires Catalyst at $31.50 a share for $4.1B July 16, 2026 3:36 AM - StreetInsider Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals July 16, 2026 3:36 AM - StreetInsider Form 25-NSE CATALYST PHARMACEUTICALS Filed by: Nasdaq Stock Market LLC July 15, 2026 9:56 AM - SEC Filing Solaris Energy Infrastructure Set to Join S&P SmallCap 600 July 9, 2026 5:48 PM - PR NewsWire Solaris Energy Infrastructure to Join S&P SmallCap 600 July 9, 2026 5:18 PM - StreetInsider Form 8-K CATALYST PHARMACEUTICALS For: Jul 08 July 8, 2026 5:30 PM - SEC Filing Form DEFA14A CATALYST PHARMACEUTICALS June 30, 2026 5:23 PM - SEC Filing Form 8-K CATALYST PHARMACEUTICALS For: Jun 30 June 30, 2026 4:58 PM - SEC Filing Catalyst Pharma reports vamorolone Phase 1 data on immune activity June 30, 2026 8:04 AM - StreetInsider Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses June 30, 2026 8:03 AM - StreetInsider Form 8-K CATALYST PHARMACEUTICALS For: Jun 22 June 23, 2026 5:15 PM - SEC Filing Form DEFM14A CATALYST PHARMACEUTICALS June 8, 2026 4:09 PM - SEC Filing Full Article List